VPA Expanded UCB Transplantation for Treatment of Patients With Hematological Malignancies
Conditions: Hematological Malignancy; Acute Leukemia in Remission; Acute Lymphoblastic Leukemia in Remission; Myelodysplastic Syndromes; Non-Hodgkin Lymphoma; Hodgkin Lymphoma Interventions: Biological: Cord blood stem cells; Drug: Valproic Acid; Drug: Fludarabine; Drug: cytoxan; Drug: Thiotepa; Biological: TBI Sponsor: Alla Keyzner Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials